← Open Payments lookup

CHAELEENA LADD: Open Payments

NPI 1518400035 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,850 in 142 payments from 19 companies in 2025. Trend: 2023 $3,214 · 2024 $2,653 · 2025 $2,850

Food & beverage: $2,759Education: $91
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP29$645
GlaxoSmithKline, LLC.24$279
United Therapeutics Corporation11$264
Grifols USA, LLC8$191
Actelion Pharmaceuticals US, Inc.6$188
Boehringer Ingelheim Pharmaceuticals, Inc.10$182
Merck Sharp & Dohme LLC7$173
Verona Pharma, Inc.8$149
ANI Pharmaceuticals, Inc.4$128
GENZYME CORPORATION6$123

Products named: BREZTRI, DUPIXENT, FASENRA, Prolastin-C Liquid, Tyvaso, Ohtuvayre, TRELEGY ELLIPTA, NUCALA.

Industry payments across MS — which companies pay providers there.